Jill De Jong

Jill De Jong is an Associate Professor at the University of Chicago in the Department of Pediatrics-Hematology and Oncology. She specializes in treating children with cancer and blood diseases, serving as Director of Pediatric Hematology and co-Director of the Pediatric Cancer Genetic Risk Clinic.

• MD, Medicine - University of Wisconsin (1999)
• PhD, Cancer Biology - University of Wisconsin (1997)
• AB, Biology - University of Chicago (1990)
• Fellowship in Pediatric Hematology-Oncology (2005)

Her research focuses on hematopoietic stem cells, genetic risks for hematologic malignancy, and genetic causes of aplastic anemia, utilizing zebrafish models for studying leukemia and blood disorders. Publications highlight expertise in bone marrow failure, autoimmune blood diseases, and hemoglobinopathies.

Key publication trends include:

• Translational studies using zebrafish for hematopoiesis (2005-2020)
• Genetic profiling of pediatric blood cancers (2023-2024)
• Clinical guidelines for aplastic anemia management (2024)

• Scientific Awards:
  • Regional Top Doctor (Pediatric Hematology-Oncology, Castle Connolly)
  • Pritzker Scholar Award (University of Chicago)
  • Alpha Omega Alpha Honor Society
  • Phi Beta Kappa

Dr. de Jong leads the Pediatric Bone Marrow Failure Clinic and contributes to evidence-based guidelines for rare blood disorders. Her work bridges basic genetics, translational oncology, and pediatric clinical care.